HLB PANAGENE Co., LTD. Logo

HLB PANAGENE Co., LTD.

A global leader in PNA technology for cancer diagnostics and precision medicine.

046210 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노10로 54, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HLB PANAGENE Co., LTD. is a global molecular diagnostics company specializing in the development and commercialization of products based on its proprietary Peptide Nucleic Acid (PNA) technology. As a leading worldwide supplier of PNA materials, the company provides innovative solutions for in-vitro diagnostics (IVD), companion diagnostics (CDx), and liquid biopsy, primarily targeting oncology and precision medicine. Its portfolio includes diagnostic kits for detecting cancer-related mutations, such as the PANA Mutyper™ series for lung cancer. The company is actively expanding its global market presence and is integrating Artificial Intelligence (AI) to develop a next-generation multimodal diagnostic platform, aiming to advance personalized healthcare and cancer diagnostics. Formerly known as Panagene Inc., the company changed its name in 2023.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HLB PANAGENE Co., LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 121.6 KB
2025-08-26 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-08-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 101.6 KB
2025-08-20 00:00
Capital/Financing Update
주권관련사채권의취득결정
Korean 38.2 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB

Automate Your Workflow. Get a real-time feed of all HLB PANAGENE Co., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HLB PANAGENE Co., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
PEPTONIC Medical AB Logo
Develops clinically proven self-care products for women's intimate health.
Sweden PMED
Develops sustained-release peptide medicines for chronic & neurodegenerative disorders.
South Korea 087010
Perseus Proteomics Inc. Logo
Develops antibody drugs for cancer, provides research support, and sells diagnostic reagents.
Japan 4882
PharmAbcine Inc. Logo
Develops antibody therapies for cancer, eye diseases, and vascular-related disorders.
South Korea 208340
Pharma Foods International Co., Ltd. Logo
Researches and sells functional ingredients and direct-to-consumer health & beauty products.
Japan 2929
Pharma Mar S.A. Logo
Develops and commercializes marine-derived oncology treatments for rare cancers.
Spain PHM
Pharmanutra Logo
Researches and markets nutritional supplements & medical devices for all ages.
Italy PHN
PHARMARESEARCH BIO Co., Ltd. Logo
A global biopharma firm creating regenerative medicine, pharmaceuticals, devices, and cosmetics.
South Korea 217950
PharmaResearch Co., Ltd. Logo
Develops regenerative medicine, devices & cosmetics using marine biotechnology.
South Korea 214450
PharmaSGP Holding SE Logo
Develops and markets leading natural OTC drugs for chronic conditions in the European market.
Germany PSG

Talk to a Data Expert

Have a question? We'll get back to you promptly.